Shots: The study involves assessing multistem therapy (IV)(n=20) vs PBO (n=10) in patients with ARDS for 28 days Study results: Lower mortality (LM)(25% vs 40%); VF days (12.9 vs 9.2); […]readmore
Tags : Multistem Cell Therapy